Piperacetazine, a new phenothiazine derivative of the piperidine series, was clinically evaluated in 75 recently admitted hospitalized psychiatric patients. It over-all effectiveness in the treatment of the acute psychiatric disorders studies appeared comparable to that of other commonly used phenothiazine derivatives. The incidence of extrapyramidal reactions was low.Abstract Teaser